You said the company "paid" CEO $14M. Now this is "not my focus". There was no such payment. The CEO exchanged some preferred shares for common shares. Net effect is zero. Posts saying there was a $14M payment are complete bullshit.
Your posts raises another question of why the warrant SURGW is $0.70 (Friday's closing price) whereas common stock SURG is $2.30 (Friday's closing price). The warrant SURGW is cheaper because even after you own the warrant you would still need to pay another $4.73 if you want to get a share of the common stock. Since SURG is trading at $2.30, the warrant SURGW is at a lower price of $0.70. This explains the "discount" between SURGW and SURG. Not sure if I can explain it any more clearly. Perhaps someone else could take a crack at it?